Use of mycophenolate mofetil for tacrolimus related chronic nephrotoxicity in liver transplant recipients

被引：0
|
作者：
Jain, A [1 ]
Fung, J [1 ]
Hamad, I [1 ]
Zuckerman, S [1 ]
Starzl, TE [1 ]
Venkataramanan, DR [1 ]
机构：
[1] UNIV PITTSBURGH,MED CTR,SCH PHARM,THOMAS E STARZL TRANSPLANTAT INST,PITTSBURGH,PA
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：427 / 427
页数：1
相关论文
共 50 条
  • [21] Mycophenolate mofetil has no effect on tacrolimus pharmacokinetics in liver transplant patients
    Hamad, JI
    Mehta, S
    Warty, V
    Virji, M
    Fung, JJ
    HEPATOLOGY, 1998, 28 (04) : 607A - 607A
  • [22] The use of daclizumab, tacrolimus and mycophenolate mofetil in African-American and Hispanic first renal transplant recipients
    Ciancio, G
    Burke, GW
    Suzart, K
    Mattiazzi, A
    Vaidya, A
    Roth, D
    Kupin, W
    Rosen, A
    Johnson, N
    Miller, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (08) : 1010 - 1016
  • [23] Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporin.
    Lobritto, SJ
    Rosenthal, P
    Bouw, R
    Leung, M
    Snell, P
    Mamelok, R
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 114 - 115
  • [24] Long-term efficacy and safety of mycophenolate mofetil with tacrolimus in orthotopic (OLT) liver transplant recipients.
    Holt, CD
    Ghobrial, MM
    Sievers, TM
    Farmer, DM
    Saab, S
    McDiarmis, SV
    Busuttil, RW
    LIVER TRANSPLANTATION, 2005, 11 (07) : C45 - C45
  • [25] No pharmacokinetic interaction between mycophenolate mofetil and tacrolimus in liver transplant recipients: a phase II exploratory study.
    Bouw, R
    Nashan, B
    Marotta, P
    Saliba, F
    Herrero, JI
    Barcena, R
    Mentha, G
    Neuhaus, P
    McKay, D
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 474 - 474
  • [26] Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results
    Hodge, EE
    Reich, DJ
    Clavien, PA
    Kim-Schluger, L
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1546 - 1547
  • [27] Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression
    Ringe, B
    Braun, F
    Wietzke, P
    Oellerich, M
    Ramadori, G
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 2543 - 2543
  • [28] A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone mycophenolate mofetil in renal transplant recipients
    Shapiro, R
    Jordan, ML
    Scantlebury, VP
    Vivas, C
    Marsh, JM
    McCauley, J
    Johnston, J
    Randhawa, P
    Irish, W
    Gritsch, HA
    Naraghi, R
    Hakala, TR
    Fung, JJ
    Starzl, TE
    TRANSPLANTATION, 1999, 67 (03) : 411 - 415
  • [29] Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity
    Filler, G
    Gellermann, J
    Zimmering, M
    Mai, I
    TRANSPLANT INTERNATIONAL, 2000, 13 (03) : 201 - 206
  • [30] Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity - A preliminary report
    Ducloux, D
    Fournier, V
    Bresson-Vautrin, C
    Rebibou, JM
    Billerey, C
    Saint-Hillier, Y
    Chalopin, JM
    TRANSPLANTATION, 1998, 65 (11) : 1504 - 1506
12345